Although previous studies have implicated a functional SALL4–TGF-β axis (45, 46), the observed reduction in TGF-β target expression may instead reflect decreased fibrotic activation associated with reduced CCA burden, rather than direct transcriptional cross-talk. Here, TGFB1 is linked to cholangiocarcinoma.